Anti-inflammatory drugs
The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised COVID-19 patients Artesunate is already used for severe malaria, imatinib for certain cancers, and infliximab for diseases of the immune system such as Crohn’s Disease and rheumatoid arthritis.
The original Solidarity trial last year found that all four treatments evaluated – Remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon – had little or no effect in helping COVID patients. So far, only corticosteroids have been proven effective against severe and critical COVID-19.
NSAIDs: NSAIDs or non-steroidal anti-inflammatory drugs are those medications used for reducing pain (analgesic), decreasing fever (anti-pyretic), preventing blood clots (anti-thrombotic) and decreasing inflammation (anti-inflammatory). NSAIDs are also used to treat non-inflammatory conditions such as migraine, period pain and postoperative pain, and to reduce fever. Some commonly used NSAIDs include:
- aspirin (such as Disprin),
- ibuprofen (such as Nurofen) ,
- naproxen (such as Naprosyn),
- diclofenac (such as Voltaren),
- celecoxib (such as Celebrex).
Note: please Comment Here for UPDATES and CORRECTIONS
Donate. Buy Us Coffee
Why news media is in crisis & How you can fix it.
India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises. But the news media is in a crisis of its own. There have been brutal layoffs and pay cuts. The best of journalism is shrinking, yielding to the crude prime-time spectacle. My digital news .in has very few young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here
Donate. https://mydigitalnews.in/donate
NOTE: Please email us for updates and corrections, if you wish to publish articles like this you can send them to info@mydigitalnews.in or mydigitalnews.in@gmail.com or you can Directicle write Articles on our Site by registering https://mydigitalnews.in/register
Disclaimer: Mydigitalnews.in provides the content from various information sources ‘as is and the content to be used only for informational purposes and not responsible for the inaccuracy or deficiency of the provided information. Mydigitalnews. in have the right, at its sole discretion, to make modifications in any aspect of the provided information.
Mydigitalnews. in Internet site may contain links to other Internet sites. While we try to link only to sites that share our high standards and respect for privacy, we are not responsible for the content or the privacy practices employed by other sites.
What's Your Reaction?
